Acquiring an established PT practice gives you immediate cash flow, payer contracts, and physician referral networks — but starting from scratch offers full control. Here's what each path actually costs in the real world.
The outpatient physical therapy market is a $47 billion industry undergoing rapid consolidation, with PE-backed platforms aggressively acquiring independent clinics while independent practitioners and entrepreneurial buyers are exploring entry from both directions. For a buyer targeting the lower middle market — clinics generating $1M–$5M in revenue — the choice between acquiring an established practice and building one from the ground up is one of the most consequential decisions you'll make. Acquisition delivers an operating business: existing payer contracts, credentialed therapists, a physician referral network built over years, and cash flow from day one. De novo development gives you a clean slate — no legacy compliance issues, no inheriting someone else's billing problems — but it demands years of runway before meaningful profitability. This analysis breaks down both paths with the specificity that PT clinic investors actually need.
Find Physical Therapy Clinic Businesses to AcquireAcquiring an existing physical therapy clinic means purchasing a functioning care delivery system — one with established payer contracts, credentialed staff, a patient census, and often a multi-year relationship with orthopedic surgeons and primary care physicians who reliably generate referrals. For buyers who want to deploy capital and generate returns within a defined horizon, acquisition is almost always the faster and lower-risk path in the PT space.
PE-backed PT platform operators pursuing tuck-in acquisitions, entrepreneurial physical therapists purchasing their first practice with SBA financing, and strategic buyers seeking immediate market presence in a specific geography or specialty niche.
Building a physical therapy clinic from scratch — the de novo path — means constructing your patient volume, payer relationships, referral network, and operational infrastructure from zero. It offers complete control over compliance posture, staffing culture, specialty focus, and technology stack, but demands significant upfront capital, patience during the ramp period, and a credible plan for physician referral development before the doors even open.
Experienced PT practice operators with existing physician relationships and capital reserves willing to absorb a multi-year ramp, or regional PT chains launching satellite locations in underserved markets where no suitable acquisition target exists.
For most buyers entering the lower middle market physical therapy space, acquisition is the strategically superior path — and often the only viable one within a 3–5 year investment horizon. The combination of SBA financing availability, immediate cash flow, existing payer infrastructure, and established physician referral networks makes acquiring a well-run PT clinic at 4x–5.5x EBITDA a far more efficient use of capital than absorbing 2+ years of de novo losses. The exception: established regional operators or PE-backed platforms with existing physician relationships and the balance sheet to fund a prolonged ramp may find de novo development worthwhile in geographies where no suitable acquisition target exists or where acquisition multiples have been bid up by consolidators. In those cases, building a satellite location adjacent to an acquired anchor practice captures the best of both paths — leveraging existing referral relationships and payer contracts while expanding footprint on a lower-cost basis.
Does the existing clinic have 2+ credentialed therapists on staff, reducing key-person dependency on the selling owner — and have you stress-tested revenue if the founder departs within 6 months of close?
What percentage of revenue comes from Medicare or a single dominant commercial insurer, and have you modeled the impact of a 5–10% reimbursement rate reduction on pro forma EBITDA?
Do you have existing physician relationships — orthopedic surgeons, sports medicine providers, or primary care networks — that could generate referrals to a de novo practice within 12 months, or would you be starting from zero?
Can you fund 18–24 months of operating losses and working capital in a build scenario, or does your investment thesis require cash flow within 6–12 months to service acquisition debt or satisfy investor returns?
Have you reviewed the target clinic's last 3 years of billing records, payer audit history, and credentialing files — and are you prepared to escrow a portion of the purchase price against undisclosed compliance liabilities?
Browse Physical Therapy Clinic Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Physical therapy clinics in the $1M–$5M revenue range typically transact at 3.5x–6x EBITDA. Clinics with diversified payer mix, multiple credentialed therapists, documented referral relationships with orthopedic surgeons, and clean billing records command the upper end of that range. Solo-therapist practices with Medicare concentration and key-person dependency trade closer to 3.5x–4x, reflecting the risk premium buyers apply to transition uncertainty.
Credentialing and contracting with commercial insurers typically takes 90–180 days per payer, and Medicare enrollment can take 60–120 days or longer depending on administrative backlogs. During this window, you cannot bill those insurers for services rendered, creating a real cash flow gap. Most de novo PT clinics plan for 6–9 months before full payer activation, requiring substantial reserve capital to cover fixed costs including rent, staff salaries, and equipment financing during the ramp period.
Yes — physical therapy clinic acquisitions are among the most SBA-eligible healthcare transactions in the lower middle market. SBA 7(a) loans are commonly used to finance PT clinic acquisitions, typically requiring 10–20% buyer equity injection with the remainder financed over 10-year terms. The key eligibility factors are the clinic's operating history (minimum 2–3 years), positive cash flow sufficient to service debt, and the buyer's relevant management or clinical experience. Sellers are often asked to hold a subordinated seller note representing 5–15% of purchase price to fill the gap between SBA loan proceeds and total transaction value.
The three highest-risk areas are billing compliance, key-person dependency, and payer concentration. Billing compliance issues — including prior Medicare or commercial insurance audits, recoupment demands, or coding errors — can create post-close liabilities that weren't visible in the P&L. Key-person dependency is a structural risk when the selling therapist personally treats the majority of patients or holds the primary physician referral relationships. Payer concentration risk arises when Medicare or a single commercial insurer represents more than 40% of revenue, leaving the practice highly vulnerable to rate reductions. A thorough due diligence process should include independent billing audits, staff interviews, and referral source mapping before close.
Physician referral relationships are among the most valuable — and most fragile — assets in a physical therapy practice sale. These relationships are built on personal trust between the referring physician and the treating therapist, which means they are often tied to the seller personally rather than to the business entity. Buyers should conduct candid conversations with key referring physicians before close, assess whether relationships can transfer to the incoming owner or clinical director, and structure earnouts tied to referral volume retention over 12–24 months post-close. Non-compete and non-solicitation agreements for the selling therapist are essential to protect these relationships during the transition period.
More Physical Therapy Clinic Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers